Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancer

Clinical Genitourinary Cancer

Volumn 12, Issue 4, 2014, Pages 287-291

  James, Andrew C ^a   Lee, Franklin C ^a   Izard, Jason P ^a   Harris, William P ^a,b   Cheng, Heather H ^a,b   Zhao, Song ^a   Gore, John L ^a   Lin, Daniel W ^a   Porter, Michael P ^a   Yu, Evan Y ^a,b   Wright, Jonathan L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Bladder cancer; Neoadjuvant chemotherapy; Pathologic stage; Radical cystectomy; Transurethral resection

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ADULT; CANCER ADJUVANT THERAPY; CANCER STAGING; CYSTECTOMY; ENDOSCOPIC SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; REVIEW; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; AGED; ENDOSCOPY; FOLLOW UP; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

AGED; CYSTECTOMY; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84904746925     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2014.01.005     Document Type: Article

References (18)

1. J.E. Montie, P.E. Clark, and M.A. Eisenberger et al. Bladder cancer J Natl Compr Canc Netw 7 2009 8 39
2. H.B. Grossman, R.B. Natale, and C.M. Tangen et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
3. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration Eur Urol 48 2005 202 205 discussion 5-6
4. P.K. Schultz, H.W. Herr, and Z.F. Zhang et al. Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up J Clin Oncol 12 1994 1394 1401
5. H.W. Herr Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol 54 2008 126 132
6. S.S. Chang, and M.S. Cookson Radical cystectomy for bladder cancer: the case for early intervention Urul Clin N Am 32 2005 147 155
7. T.A. Splinter, H.I. Scher, and L. Denis et al. The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer-Genitourinary Group J Urol 147 1992 606 608
8. H. von der Maase, S.W. Hansen, and J.T. Roberts et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 2000 3068 3077
9. J.A. Efstathiou, D.Y. Spiegel, and W.U. Shipley et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience Eur Urol 61 2012 705 711
10. C. Rodel, G.G. Grabenbauer, and R. Kuhn et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results J Clin Oncol 20 2002 3061 3071
11. D. Leibovici, W. Kassouf, and L.L. Pisters et al. Organ preservation for muscle-invasive bladder cancer by transurethral resection Urology 70 2007 473 476
12. C.N. Sternberg, V. Pansadoro, and F. Calabro et al. Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 97 2003 1644 1652
13. R.W. deVere White, P.N. Lara Jr., and B. Goldman et al. A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219) J Urol 181 2009 2476 2480 discussion 80-1
14. M. Deraco, S. Kusamura, and S. Virzi et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial Gynecol Oncol 122 2011 215 220
15. L. Ansaloni, V. Agnoletti, and A. Amadori et al. Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer Int J Gynecol Cancer 22 2012 778 785
16. M. Deraco, S. Virzi, and D.R. Iusco et al. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study BJOG: an international journal of obstetrics and gynaecology 119 7 2012 Jun 800 809 PubMed PMID: 22571746. Epub 2012/05/11. eng
17. R.C. Flanigan, S.E. Salmon, and B.A. Blumenstein et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 2001 1655 1659
18. R. Sawhney, D. Bourgeois, and U.B. Chaudhary Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead Ann Oncol 17 2006 1360 1369